HBV Drugs Cut Risk of Cancer Recurrence (CME/CE)

BOSTON (MedPage Today) — Antiviral therapy after surgery appears to reduce the risk of recurrence of hepatocellular carcinoma related to hepatitis B, a researcher reported here.

Post a Comment

Comments are closed.